The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holz, A.
Right arrow Articles by Oldstone, M. B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holz, A.
Right arrow Articles by Oldstone, M. B. A.
The Journal of Immunology, 2000, 165: 5945-5953.
Copyright © 2000 by The American Association of Immunologists

Neither B Lymphocytes Nor Antibodies Directed Against Self Antigens of the Islets of Langerhans Are Required for Development of Virus-Induced Autoimmune Diabetes1 ,2

Andreas Holz3,*, Thomas Dyrberg{dagger}, William Hagopian{ddagger}, Dirk Homann*, Matthias von Herrath* and Michael B. A. Oldstone*

* Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037; {dagger} Novo Nordisk A/S, Bagsvaerd, Denmark; and {ddagger} Pacific Northwest Research Institute, University of Washington, Department of Medicine, Seattle, WA 98195

We evaluated the role of the humoral arm of the immune response in causing or contributing to virus-induced diabetes. Transgenic mice expressing the nucleoprotein (NP) or glycoprotein (GP) of the lymphocytic choriomeningitis virus (LCMV) under control of the rat insulin promoter (RIP) in pancreatic {beta} cells (RIP-LCMV) and RIP-LCMV mice with genetic dysfunction of B cells (RIP-LCMV x µMT/µMT) were compared for development of diabetes after challenge with LCMV. After inoculation with LCMV, B and T lymphocytes and macrophages infiltrated into pancreatic islets in RIP-LCMV mice, and over 50% of these mice generated Abs against host insulin or glutamate decarboxylase. However, neither B cells nor the autoantibodies played a direct role in the initiation, kinetics, or severity of the virus-induced diabetes as judged by comparing disease in RIP-LCMV mice to littermates whose functional B cells were genetically eliminated. Furthermore, the quality and quantity of T lymphocyte and macrophage infiltration was similar in the B cell-deficient and non-B cell-deficient RIP-LCMV mice. Although the development of autoantibodies to islet Ags had no direct influence on the pathogenesis of insulin-dependent (type 1) diabetes mellitus, it served as a prediabetes marker, as such autoantibodies were often elevated before the onset of disease. Hence, the RIP-LCMV model is not only useful for understanding the pathogenetic mechanisms of how islets are destroyed and spared but also for evaluating therapeutic strategies before onset of clinical diabetes.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Rhode, M. E. Pauza, A. M. Barral, E. Rodrigo, M. B. A. Oldstone, M. G. von Herrath, and U. Christen
Islet-Specific Expression of CXCL10 Causes Spontaneous Islet Infiltration and Accelerates Diabetes Development
J. Immunol., September 15, 2005; 175(6): 3516 - 3524.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. E. Juedes, E. Rodrigo, L. Togher, L. H. Glimcher, and M. G. von Herrath
T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes
J. Exp. Med., April 19, 2004; 199(8): 1153 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
G. Del Pozzo, D. Mascolo, A. Prisco, P. Barba, A. Anzisi, and J. Guardiola
Lack of patent liver autoimmunity after breakage of tolerance in a mouse model
Int. Immunol., October 1, 2003; 15(10): 1173 - 1181.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.